PRIME-XV T Cell CDM is the first commercially-available, chemically defined, animal component-free medium for the expansion and transduction of human T cells. The formulation is optimized to deliver consistently vigorous growth while maintaining T cell functionality and potency. Chemically defined, animal component-free T cell culture medium • Supports T cell expansion in static and dynamic automation systems while maintaining functionality
- Eliminates the adverse effects undefined components cause on T cell phenotypes
- Supports polarization to targeted T cell types, such as Th1, Th2, cytotoxic T cells, to further possible therapy applications
- Performs transduction of T cells without requiring spinoculation or transduction enhancers Designed and manufactured to facilitate transfer from research to clinic. Supported by robust raw material controls and supply chain management:
- FDA, Federal, and State registered - cGMP-compliant manufacture
- EN ISO 13485:2016 certified
- MDSAP certified
- Extensive QC testing including functionality, sterility (USP <71>), endotoxin (USP <85>), and mycoplasma (USP <63>)
- Drug Master Files (DMFs) filed with the FDA – available upon request
Chemically defined and animal component-free medium for T cell culture. PRIME-XV T Cell CDM supports viable T cell expansion across different culture vessels. 1L, 12 month shelf life